Work

Studies of High Doses of a Human Immunodeficiency Virus Type 1 Recombinant Glycoprotein 160 Candidate Vaccine in HIV Type 1-Seronegative Humans

Year: 1994

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: AIDS Research and Human Retroviruses

DOI: 10.1089/aid.1994.10.1713

Authors: Michael C. Keefer, Barney S. Graham, Robert B. Belshe, David Schwartz, Lawrence Corey, Dani P. Bolognesi, Donald M. Stablein, David C. Montefiori, M. Juliana McELRATH, Mary Lou Clements, Geoffrey J. Gorse, Peter F. Wright, Thomas J. Matthews, Gale E. Smith, Dale Lawrence, Raphael Dolin

Institutions: University of Rochester Medicine, University of Rochester

Language: English

Topic: HIV Research and Treatment

Subfield: Virology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Institute of Allergy and Infectious Diseases

Awards: AIDS VACCINE EVALUATION UNIT, AIDS VACCINE EVALUATION UNIT, G3603981032, AIDS VACCINE EVALUATION UNIT, G8350234157, G952203527

OpenAlex ID: W2052220933

FWCI: 1.454

Cites: 24

Cited by: 65

Related to: 10